@article{TCR35044,
author = {Daniele Lavacchi and Sara Fancelli and Marta Rita Gatta Michelet and Martina Catalano and Giandomenico Roviello},
title = {REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer},
journal = {Translational Cancer Research},
volume = {9},
number = {2},
year = {2020},
keywords = {},
abstract = {Lee et al. (1) evaluated the efficacy and safety of bevacizumab in combination with single-agent chemotherapy for platinum-resistant ovarian cancer in a large retrospective analysis involving Korean women with platinum-resistant recurrent ovarian cancer from 27 different institutions.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/35044}
}